BACKGROUND: Given the paucity of relevant data, this study estimates the cost of intellectual disability (ID) to families and the government in Australia. METHOD: Family costs were collected via the Client Service Receipt Inventory, recording information relating to service use and personal expense as a consequence of ID. Government expenditure on the provision of support and services was estimated using top-down costing. RESULTS: A total of 109 parents participated. The cost of ID in Australia is high, especially for families. Total economic costs of ID are close to $14,720 billion annually. Opportunity cost of lost time provided 85% of family expense. A comparison of family expense and social welfare benefits received suggests that families suffer considerable loss. This may impact on families' physical and emotional wellbeing. CONCLUSIONS: Monitoring of changes in expenditure is required. Policies should ensure that money devoted to ID is allocated in a rational, equitable, and cost-effective manner.
BACKGROUND: Given the paucity of relevant data, this study estimates the cost of intellectual disability (ID) to families and the government in Australia. METHOD: Family costs were collected via the Client Service Receipt Inventory, recording information relating to service use and personal expense as a consequence of ID. Government expenditure on the provision of support and services was estimated using top-down costing. RESULTS: A total of 109 parents participated. The cost of ID in Australia is high, especially for families. Total economic costs of ID are close to $14,720 billion annually. Opportunity cost of lost time provided 85% of family expense. A comparison of family expense and social welfare benefits received suggests that families suffer considerable loss. This may impact on families' physical and emotional wellbeing. CONCLUSIONS: Monitoring of changes in expenditure is required. Policies should ensure that money devoted to ID is allocated in a rational, equitable, and cost-effective manner.
Authors: Emin D Ozkan; Thomas K Creson; Enikö A Kramár; Camilo Rojas; Ron R Seese; Alex H Babyan; Yulin Shi; Rocco Lucero; Xiangmin Xu; Jeffrey L Noebels; Courtney A Miller; Gary Lynch; Gavin Rumbaugh Journal: Neuron Date: 2014-06-18 Impact factor: 17.173
Authors: Karine Chevreul; Coralie Gandré; Karen Berg Brigham; Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; László Gulácsi; Johann Matthias Graf von der Schulenburg; Panos Kanavos; Ulf Persson; Giovani Fattore Journal: Eur J Health Econ Date: 2016-04-12
Authors: Kerry K Hall; Anne B Chang; Theo P Sloots; Jennie Anderson; Anita Kemp; Jan Hammill; Michael Otim; Kerry-Ann F O'Grady Journal: BMC Pediatr Date: 2015-05-14 Impact factor: 2.125
Authors: Daryl Efron; Kaitlyn Taylor; Jonathan M Payne; Jeremy L Freeman; Noel Cranswick; Melissa Mulraney; Chidambaram Prakash; Katherine J Lee; Katrina Williams Journal: BMJ Open Date: 2020-03-08 Impact factor: 2.692
Authors: Charles H Hensel; Rena J Vanzo; Megan M Martin; Ling Ling; Solange M Aliaga; Minh Bui; David I Francis; Hope Twede; Michael H Field; Jonathon W Morison; David J Amor; David E Godler Journal: Sci Rep Date: 2019-10-25 Impact factor: 4.379